Trial Profile
A Multi-center, Randomized, 12-week Treatment, Doubleblind Study to Assess the Efficacy and Safety of QMF149 (150/80 Microgram) Compared With MF Twisthaler (200 Microgram) in Adult and Adolescent Patients With Asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2022
Price :
$35
*
At a glance
- Drugs Indacaterol/mometasone (Primary) ; Mometasone
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms QUARTZ
- Sponsors Novartis; Novartis Pharmaceuticals
- 24 Jan 2022 A review outlining the unique strategy used in the accelerated development of IND/GLY/MF that combined various approaches comprising data from 3 study (QUARTZ and PALLADIUM evaluated IND/MF while IRIDIUM and ARGON evaluated IND/GLY/MF) published in the Advances in Therapy
- 27 Jan 2021 Results of a pooled analysis assessing cardiovascular safety from four clinical studies: PALLADIUM, IRIDIUM, ARGON and QUARTZ published in the Respiratory Medicine
- 01 Jan 2020 Results published in the Respiratory Medicine